Scott Bergman, Pharm.D., BCPS (AQ ID)
Bachelor of Science – Pharmaceutical Sciences, 2002. South Dakota State University – Brookings, S.D.
Doctor of Pharmacy, 2004. South Dakota State University College of Pharmacy – Brookings, S.D.
Pharmacy Practice Residency, 2004-05. West Virginia University Hospitals – Morgantown, W.V.
Infectious Diseases Specialty Pharmacy Residency, 2005-2006, West Virginia University Hospitals and School of Pharmacy – Morgantown, W.V.
PHPT 725: Integrated Pharmacotherapeutics – Infectious Diseases
PHPR 749: Vaccine-Preventable Diseases and Immunization Training
PHEL 774: Advanced Infectious Diseases Pharmacotherapy
PHEP 784-786: Advanced Pharmacy Practice Experiences, patient care elective rotation in infectious diseases.
Dr. Bergman’s office is at the SIU School of Medicine with the Division of Infectious Diseases. He rounds with physicians, fellows, residents and students on patients at both Memorial Medical Center and St. John’s Hospital in Springfield. He also practices at the SIU Healthcare Clinic where he sees international travelers and patients who have HIV or hepatitis C.
He has been residency program director for the PGY2 Infectious Diseases Pharmacy Residency since 2012. Click here for more information on the residency programs at St. John’s Hospital.
Antimicrobial use for infections, microbial biofilms, immunizations and rapid-diagnostic testing
Shah PJ, Bergman SJ, Graham D, Glenn S. Monitoring of outpatient parenteral antimicrobial therapy (OPAT) and implementation of clinical pharmacy services at a community hospital infusion unit. Journal of Pharmacy Practice (in-press).
Shah PJ. Bergman S, Vegi S, Sundareshan S. Fusarium peritonitis successfully managed with posaconazole and catheter removal. Peritoneal Dialysis International (in-press).
Klepser ME, Hagerman JK, Klepser SA, Bergman SJ, Klepser DG. A community pharmacy-based influenza screening and management program shortens time to treatment versus pharmacy screening with referral to standard of care. Illinois Pharmacist. 2014; 76 (2): 12-18.
Bergman SJ, Shah PJ. Chapter 139. Dermatophytosis: Toeing the Line. In: Schwinghammer TL, Koehler JM, eds. Pharmacotherapy Casebook: A Patient-Focused Approach. 9th ed. New York: McGraw-Hill; 2014. p. 361-363.
Percival KM, Bergman SJ. Update on posaconazole pharmacokinetics: Comparison of new and old formulations. Current Fungal Infection Reports. 2014; 8: 139-145.
Santanello CD, Dow AC, Bergman SJ. Active Learning Strategies: Student Perceptions. Academic Exchange Quarterly. 2014; 18 (1):24-34.
Bergman SJ, Doss MM, Connor-Hustedde H. Fungal Infections. In: Mason B, Parker D, Lott RS, editors. Capstone Pharmacy Review. Burlington: Jones and Bartlett; 2014. p. 324-343.
Campbell-Petkewicz KA, Bergman SJ, Otsuka ST, Collins-Lucey EH. Immunizations. In: Mason B, Parker D, Lott RS, eds. Capstone Pharmacy Review. Burlington: Jones and Bartlett; 2014. p. 712-720.
Santanello CD, Bergman, SJ. Sarah’s Sickness: The Diagnosis and Treatment of an Infectious Disease. [Case Study] 2014. Buffalo, NY: National Center for Case Study Teaching in Science, University at Buffalo, State University of New York. http://sciencecases.lib.buffalo.edu/cs/collection/detail.asp?case_id=721&id=721
Schmees PM, Bergman SJ, Strader BD, Metzke ME, Pointer S, Valenti KM,. Outcomes Of An Extended-Infusion Piperacillin-Tazobactam Protocol Implementation In A Community Teaching Hospital Adult Intensive Care Unit. Journal of Health-System Pharmacy Residents. 2013; 2 (2): 1-8.
Bergman SJ, Collins-Lucey EH. Update on Human Papillomavirus Vaccines: Life Saver or Controversy Magnet? Clinical Microbiology Newsletter. 2012; 34(11) 85-91.
Bergman SJ, Ferguson M, Santanello C. Interferons as therapeutic agents for infectious diseases. Infectious Disease Clinics of North America. 2011; 25(4): 819-834.
Bergman SJ, Tyagi I, Ronald K. Antifungal dosing in critically ill patients. Current Fungal Infection Reports. 2010; 4(2): 78-86.
Htwe TH, Bergman S, Koirala J. Famcicovir substitution for patients with acyclovir-associated renal toxicity. Journal of Infection, 2008; 57: 266-268.
Bergman SJ, Speil C, Short M, Koirala JK. Pharmacokinetic and pharmacodynamic aspects of antibiotic use in high risk populations. Infectious Disease Clinics of North America. 2007; 21 (3) Sept: 821-846.